http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2127112-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
filingDate | 1992-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1999-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_880b0baf5dcbb80e975f2e404610faa4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bb323eb38aa46bee0e1729b48f7915e |
publicationDate | 1999-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2127112-C1 |
titleOfInvention | Estrogen (progestin)-anitoprogestin method of peroral contraception and menstruation control, pharmaceutical composition, and assembly of drugs |
abstract | FIELD: gynecology. SUBSTANCE: method consists in that estrogen or estrogen with progestin is administered every day without break in doses blocking folliculogenesis. At at least one month intervals, menstruation is stimulated by administering antiprogestin in doses efficient to reject accumulated endometrial tissue. Adequate pharmaceutical compositions and drug sets are provided. EFFECT: eliminated sudden uterine bleeding caused by small estrogen doses. 48 cl, 2 ex |
priorityDate | 1992-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.